Twinbeech Capital LP Harmony Biosciences Holdings, Inc. Transaction History

Twinbeech Capital LP

  • $4.99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$19.2 - $33.78 $1.26 Million - $2.21 Million
65,421 New
65,421 $2.11 Million
Q1 2023

May 15, 2023
BUY
$30.8 - $53.92 $452,729 - $792,570
14,699 New
14,699 $479,000
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $2.66 Million - $3.51 Million
63,220 New
63,220 $2.8 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.08B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email